Cargando…
Drug repurposing in pharmaceutical industry and its impact on market access: market access implications
BACKGROUND: Drug repurposing is a group of development strategies employed in order to overcome some of the hurdles innate to drug research and development. Drug repurposing includes drug repositioning, reformulation and combination. OBJECTIVE: This study aimed to identify the determinants of succes...
Autores principales: | Murteira, Susana, Millier, Aurélie, Toumi, Mondher |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Co-Action Publishing
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4865758/ https://www.ncbi.nlm.nih.gov/pubmed/27226833 http://dx.doi.org/10.3402/jmahp.v2.22814 |
Ejemplares similares
-
Drug reformulations and repositioning in the pharmaceutical industry and their impact on market access: regulatory implications
por: Murteira, Susana, et al.
Publicado: (2014) -
New drug regulations in France: what are the impacts on market access? Part 2 – impacts on market access and impacts for the pharmaceutical industry
por: Rémuzat, Cécile, et al.
Publicado: (2013) -
Drug reformulations and repositioning in pharmaceutical industry and its impact on market access: reassessment of nomenclature
por: Murteira, Susana, et al.
Publicado: (2013) -
Proposed changes to the reimbursement of pharmaceuticals and medical devices in Poland and their impact on market access and the pharmaceutical industry
por: Badora, Karolina, et al.
Publicado: (2017) -
Market access agreements for pharmaceuticals in Europe: diversity of approaches and underlying concepts
por: Jarosławski, Szymon, et al.
Publicado: (2011)